Vir Biotechnology to Host a Call on Sotrovimab’s Retained Activity Against the Omicron SARS-CoV-2 Variant
December 07, 2021 03:55 ET
|
Vir Biotechnology, Inc.
SAN FRANCISCO, Dec. 07, 2021 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) announced that Management will host a conference call at 8:30 am ET, Tuesday, December 7, 2021, to discuss new...
Preclinical Studies Demonstrate Sotrovimab Retains Activity Against the Full Combination of Mutations in the Spike Protein of the Omicron SARS-CoV-2 Variant
December 07, 2021 03:48 ET
|
Vir Biotechnology, Inc.
– New preclinical findings generated through in vitro testing of sotrovimab againstthe complete pseudo-virus updated to bioRxiv – Data build on promising signal published last week, underscoring the...
Global Research Antibodies Outlook to 2028: Rise in R&D Initiatives and an Increase in Neurobiology and Stem Cell Research are Key Factors in Market Advancement
December 03, 2021 11:23 ET
|
Research and Markets
Dublin, Dec. 03, 2021 (GLOBE NEWSWIRE) -- The "Global Research Antibodies Market Size, Share & Trends Analysis Report by Product (Primary, Secondary), by Type (Monoclonal Antibodies, Polyclonal...
Preclinical Data Demonstrate Sotrovimab Retains Activity Against Key Omicron Mutations, New SARS-CoV-2 Variant
December 02, 2021 02:07 ET
|
Vir Biotechnology, Inc.
– Preclinical data demonstrate sotrovimab, authorized in multiple countries around the world, retains activity against all tested variants of concern, including key mutations of Omicron – – Data to...
Unituxin Patent, Sales & Clinical Trials Guide 2021-2028, Featuring Bellicum Therapeutics, MabVax Therapeutics, Sinobioway Cell Therapy and United Therapeutic Corporation
November 26, 2021 06:58 ET
|
Research and Markets
Dublin, Nov. 26, 2021 (GLOBE NEWSWIRE) -- The "Unituxin Patent, Sales & Clinical Trials Outlook 2028" report has been added to ResearchAndMarkets.com's offering. Neuroblastoma is an embryonic...
Single-Use Bioreactors Market size worth $ 11,603.32 Million, Globally, by 2028 at 19.36% CAGR: Verified Market Research®
November 24, 2021 10:15 ET
|
Verified Market Research
Jersey City, New Jersey, Nov. 24, 2021 (GLOBE NEWSWIRE) -- Verified Market Research recently published a report, “Single-Use Bioreactors Market” By Application (Process Development, Research, and...
Emerging Issues in Biopharmaceutical Manufacturing in 2021
November 19, 2021 06:38 ET
|
Research and Markets
Dublin, Nov. 19, 2021 (GLOBE NEWSWIRE) -- The "18th Annual Report and Survey on Biopharmaceutical Manufacturing Capacity and Production" report has been added to ResearchAndMarkets.com's offering. ...
GSK and Vir Biotechnology Announce United States Government Agreements to Purchase Sotrovimab, a COVID-19 Treatment
November 17, 2021 06:42 ET
|
Vir Biotechnology, Inc.
– US government contracts for approximately $1 billion1 (USD) now in place to purchase sotrovimab, further expanding access nationwide – – This brings the total number of doses secured through...
Global $5.8 Billion Research Antibodies Market to 2028 with COVID-19 Being a Major Contributing Factor
November 15, 2021 04:38 ET
|
Research and Markets
Dublin, Nov. 15, 2021 (GLOBE NEWSWIRE) -- The "Research Antibodies Market Share, Size, Trends, Industry Analysis Report, By Product; By Type; By Technologies; By Source; By Application; By End-Use;...
Primary endpoint met in COMET-TAIL Phase 3 trial evaluating intramuscular administration of sotrovimab for early treatment of COVID-19
November 12, 2021 07:10 ET
|
Vir Biotechnology, Inc.
– COMET-TAIL Phase 3 data demonstrated that intramuscular administration of sotrovimab was non-inferior and offered similar efficacy to intravenous administration for high-risk populations – – The...